Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery
Study Information
Alliance Study ID: ACOSOG-Z0040
NCT Study ID (ClinicalTrials.gov): NCT00003901
Disease or Cancer Type: Lung Cancer & Mesothelioma
Alliance Study Chair: Robbin G. Cohen, MD
Status: COMPLETED
Study Description
RATIONALE: Prognostic testing for early signs of metastases may help doctors detect metastases early and plan more effective treatment.
PURPOSE: Phase III trial to study the relationship between early signs of metastases and survival in patients who have stage I, stage II, or stage III non-small cell lung cancer that can be removed by surgery.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information